Morphological anomalies of circulating blood cells in COVID-19.
作者信息
Zini Gina, Bellesi Silvia, Ramundo Francesco, d'Onofrio Giuseppe
机构信息
Università Cattolica del Sacro Cuore, Rome, Italy.
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
出版信息
Am J Hematol. 2020 Jul;95(7):870-872. doi: 10.1002/ajh.25824. Epub 2020 Apr 22.
Abstract
摘要
相似文献
1
Morphological anomalies of circulating blood cells in COVID-19.新型冠状病毒肺炎中循环血细胞的形态异常
Am J Hematol. 2020 Jul;95(7):870-872. doi: 10.1002/ajh.25824. Epub 2020 Apr 22.
2
Peripheral blood morphologic findings in patients with COVID-19.新型冠状病毒肺炎患者的外周血形态学表现
Int J Lab Hematol. 2020 Dec;42(6):e248-e251. doi: 10.1111/ijlh.13300. Epub 2020 Jul 30.
3
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).新型冠状病毒2型感染（新冠肺炎）中的浆细胞样淋巴细胞
Am J Hematol. 2020 Jul;95(7):861-862. doi: 10.1002/ajh.25834. Epub 2020 Apr 28.
4
Sex differences in COVID-19 course and outcome: progesterone should not be neglected.COVID-19病程及预后的性别差异：孕酮不容忽视。
J Appl Physiol (1985). 2020 Nov 1;129(5):1007-1008. doi: 10.1152/japplphysiol.00740.2020.
5
Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.ABO血型与新型冠状病毒肺炎风险之间的关联。
Br J Haematol. 2020 Jul;190(1):24-27. doi: 10.1111/bjh.16797. Epub 2020 May 26.
6
Insights into pediatric multi-system inflammatory syndrome and COVID-19.儿童多系统炎症综合征与新型冠状病毒肺炎的见解
Clin Chim Acta. 2020 Nov;510:121-122. doi: 10.1016/j.cca.2020.07.025. Epub 2020 Jul 14.
7
COVID-19 and thrombosis: Beyond a casual association.新型冠状病毒肺炎与血栓形成：不仅仅是偶然关联。
Med Clin (Barc). 2020 Jul 10;155(1):44. doi: 10.1016/j.medcli.2020.04.014. Epub 2020 May 11.
8
The association between COVID-19 and asthma: A systematic review and meta-analysis.2019冠状病毒病与哮喘之间的关联：一项系统评价和荟萃分析。
Clin Exp Allergy. 2020 Nov;50(11):1274-1277. doi: 10.1111/cea.13733. Epub 2020 Sep 24.
9
EPO in Patients With COVID-19: More Than an Erythropoietic Hormone.新冠病毒肺炎患者体内的促红细胞生成素：不止是一种促红细胞生成激素。
Am J Kidney Dis. 2020 Sep;76(3):441. doi: 10.1053/j.ajkd.2020.06.002. Epub 2020 Jun 10.
10
COVID-19 infection in patients with sickle cell disease.镰状细胞病患者的新型冠状病毒肺炎感染
Br J Haematol. 2020 Jun;189(5):851-852. doi: 10.1111/bjh.16734. Epub 2020 May 8.
引用本文的文献
1
Prior COVID-19 infection increases degenerated oocytes but does not affect IVF outcomes: a prospective cohort study.既往新冠病毒感染会增加退化卵母细胞数量，但不影响体外受精结局：一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2025 May 22;16:1599771. doi: 10.3389/fendo.2025.1599771. eCollection 2025.
2
Impact of the COVID-19 pandemic on care delivery, follow-up and outcomes in chronic myeloid leukemia patients: An observational cohort study.2019冠状病毒病大流行对慢性髓性白血病患者的治疗、随访及结局的影响：一项观察性队列研究
Bioinformation. 2024 Dec 31;20(12):1813-1818. doi: 10.6026/9732063002001813. eCollection 2024.
3
Multi-Channel Cellytics for Rapid and Cost-Effective Monitoring of Leukocyte Activation.用于快速且经济高效地监测白细胞激活的多通道细胞溶解技术
Biosensors (Basel). 2025 Feb 24;15(3):143. doi: 10.3390/bios15030143.
4
Adversarial training collaborating hybrid convolution-transformer network for automatic identification of reactive lymphocytes in peripheral blood.用于外周血中反应性淋巴细胞自动识别的对抗训练协作混合卷积-Transformer网络
Biomed Opt Express. 2024 Aug 9;15(9):5143-5161. doi: 10.1364/BOE.525119. eCollection 2024 Sep 1.
5
MDS-Type Morphologic Abnormalities of Peripheral Blood Granulocytes in Symptomatic COVID-19 Patients.有症状的新冠肺炎患者外周血粒细胞的MDS型形态学异常
Int J Hematol Oncol Stem Cell Res. 2024 Jul 1;18(3):249-253. doi: 10.18502/ijhoscr.v18i3.16105.
6
Morphological abnormalities of leukocytes in SARS-CoV-2 infection.严重急性呼吸综合征冠状病毒 2 感染患者白细胞的形态学异常。
Afr Health Sci. 2023 Dec;23(4):102-107. doi: 10.4314/ahs.v23i4.13.
7
Analysis of the Morphology of Monocytes and Lymphocytes from COVID-19 Patients Using Low-Voltage Scanning Electronic Microscopy.利用低电压扫描电子显微镜分析 COVID-19 患者的单核细胞和淋巴细胞形态。
Bull Exp Biol Med. 2023 Dec;176(2):297-302. doi: 10.1007/s10517-024-06011-4. Epub 2024 Jan 9.
8
Hematocytological Clues of Peripheral Blood in Different Clinical Presentations of COVID-19.新型冠状病毒肺炎不同临床表现中外周血的血细胞学线索
Iran J Pathol. 2023 Summer;18(3):270-278. doi: 10.30699/IJP.2023.561331.2963. Epub 2023 Jul 16.
9
Leukocyte cell population data as potential markers of COVID-19 disease characterization.白细胞细胞群体数据作为新冠病毒疾病特征的潜在标志物。
J Med Biochem. 2023 Aug 25;42(3):454-459. doi: 10.5937/jomb0-41589.
10
Increased red blood cell deformation in children and adolescents after SARS-CoV-2 infection.儿童和青少年感染 SARS-CoV-2 后红细胞变形能力增加。
Sci Rep. 2023 Jun 17;13(1):9823. doi: 10.1038/s41598-023-35692-6.
本文引用的文献
1
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下：一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.
2
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.新型冠状病毒肺炎外周血淋巴细胞亚群特征变化。
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
3
Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: Letter from the warfront….新冠疫情爆发时的教皇若望二十三世贝加莫医院：来自抗疫前线的信……
Int J Lab Hematol. 2020 Jun;42 Suppl 1:8-10. doi: 10.1111/ijlh.13207.
4
Leukoerythroblastic reaction in a patient with COVID-19 infection.一名新冠肺炎感染患者的类白血病反应。
Am J Hematol. 2020 Aug;95(8):999-1000. doi: 10.1002/ajh.25793. Epub 2020 Apr 6.
5
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
6
Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series.中国浙江 91 例 COVID-19 住院患者的流行病学和临床特征：一项回顾性、多中心病例系列研究。
QJM. 2020 Jul 1;113(7):474-481. doi: 10.1093/qjmed/hcaa089.
7
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
8
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China.中国武汉2019年新型冠状病毒肺炎难治性病例的临床特征
Clin Infect Dis. 2021 Dec 6;73(11):e4208-e4213. doi: 10.1093/cid/ciaa270.
9
Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression.COVID-19 患者可能受益于持续的洛匹那韦联合治疗方案，而嗜酸性粒细胞的增加可能预测 COVID-19 进展的结果。
Int J Infect Dis. 2020 Jun;95:183-191. doi: 10.1016/j.ijid.2020.03.013. Epub 2020 Mar 12.
10
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
Zotero 插件